2016 Jan 19
Prognostic factors and the impact of new therapies for CLL
Richard Furman, M.D., discusses therapies for chronic lymphocytic leukemia. Read more
2016 Jan 18
Expert discusses emerging agents and the future of follicular lymphoma
When it comes to treating follicular lymphoma, oncologists must carefully consider treatments, says John P. Leonard, M.D. Read more
2016 Jan 18
Gene sequencing effort helps pinpoint cancer treatments
Precision medicine is helping cancer patients at Weill Cornell Medicine. Read more
2016 Jan 17
Moonshot to Cure Cancer
Dean Laurie Glimcher, M.D., talks about scientific discoveries combating cancer. Read more
2016 Jan 14
Privacy in the post-genomic era: Impossible
Chris Mason, Ph.D., discusses consumer genomics at a healthcare conference. Read more
2016 Jan 14
Cantley among 7 Wolf Prize laureates
Meyer director Lewis Cantley, Ph.D, has been awarded "Israel's Nobel Prize." Read more
2016 Jan 14
Is the cure for cancer real or rhetoric?
Harold Varmus, M.D., comments on Vice President Joe Biden's "moonshot" effort to cure cancer. Read more
2016 Jan 13
Getting a GRASP on the R01 Funding Process
The new Grant Review and Support Program (GRASP) at Weill Cornell Medicine is training assistant professor and instructor level investigators to successfully submit their first National Institutes of Health (NIH) R01 proposal. Read more
2016 Jan 12
Engineering tumor environments for study
Feature on the research of Cornell University member Claudia Fischbach-Teschl, Ph.D. Read more
2016 Jan 11
Increased funding for medical research is a terrific first step
Dean Laurie Glimcher, M.D., pens a piece about federal funding for medical research. Read more
2016 Jan 11
Batting it out of the park
Ph.D. student Katie Gayvert's "Moneyball" approach to cancer involves a computational model to screen for drugs that are too toxic to tolerate. Read more
2016 Jan 06
Eli Lilly, Pfizer, J&J, AbbVie join $48M bet on NYC cancer drug startup
Director Lewis Cantley, Ph.D., is heading a new pharmaceutical venture. Read more
2016 Jan 04
30 Under 30
Graduate students Kaitlyn Gayvert and Neel Madhukar were named to prestigious Forbes list Read more
2015 Dec 29
Glembatumumab vedotin as a treatment in Triple Negative Breast Cancer
Linda Vahdat, M.D., discusses the antibody drug conjugate glembatumumab vedotin in the treatment of women with triple negative breast cancer. Read more
2015 Dec 23
CLL Research Highlights From ASH 2015
Richard Furman, M.D., gives a rundown of research and treatment advances for chronic lymphocytic leukemia Read more
2015 Dec 22
Immune checkpoint inhibition an ‘important new frontier’ in lymphoma
John P. Leonard, M.D., discusses immune checkpoint inhibitors at the Lymphoma & Myeloma 2015 conference. Read more
2015 Dec 17
Comparing therapies for Hodgkin's lymphoma in varied populations
Peter Martin, M.D., comments on studies comparing therapies for Hodgkin's lymphoma. Read more
2015 Dec 15
New horizons for interferon therapy in MPNs
Richard Silver, M.D., discusses interferon therapy for the treatment of myeloproliferative neoplasms. Read more
2015 Dec 15
Emerging strategies for treating progressive indolent B-Cell NHL
John P. Leonard, M.D., presented on indolent B-Cell NHL treatment at the recent Chemotherapy Foundation Symposium. Read more
